Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who are healthy enough to undergo surgery
- People whose breathing and heart function have been assessed and found to be at low risk for surgery
- People who have clearly stated they are willing to follow the trial's requirements
- People who have tumor tissue available that can be used for genetic testing
Who may not be able to join:
- Women who are able to become pregnant, are currently pregnant, are breastfeeding, or plan to become pregnant during the study
- People who have another illness, health condition, or abnormal test result that the trial team considers a reason not to participate (confirm with trial site)
- People who have had a serious infection recently or are currently dealing with one
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lorenzo Spaggiari, European Institute of Oncology
Phone: +390257489244
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To investigate the molecular differences between primitive lung cancer and the metastatic site.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.